HUMACYTE INC
NASDAQ: HUMA (Humacyte, Inc.)
Kemas kini terakhir: 1 jam lalu0.597
0.03 (4.59%)
| Penutupan Terdahulu | 0.570 |
| Jumlah Dagangan | 5,172,296 |
| Harga / Pendapatan (P/E Ke hadapan) | 35.84 |
| Harga / Jualan (P/S) | 52.31 |
| Harga / Buku (P/B) | 5.07 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -4,484.33% |
| EPS Cair (TTM) | -0.690 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 228.93% |
| Nisbah Semasa (MRQ) | 3.68 |
| Aliran Tunai Operasi (OCF TTM) | -99.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -67.40 M |
| Pulangan Atas Aset (ROA TTM) | -42.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -249.75% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Humacyte, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.38 |
|
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 20.16% |
| % Dimiliki oleh Institusi | 40.20% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Antipodes Partners Ltd | 30 Jun 2026 | 10,103,647 |
| Great Point Partners I Lp | 30 Jun 2026 | 3,750,000 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| JONES KEITH ANTHONY | 0.681 | - | 10,000 | 6,810 |
| Jumlah Keseluruhan Kuantiti Bersih | 10,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 6,810 | |||
| Purata Pembelian Keseluruhan ($) | 0.681 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| JONES KEITH ANTHONY | Pengarah | 20 Aug 2026 | Beli (+) | 10,000 | 0.681 | 6,810 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |